Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
09:30 - 09:30 | Presenter: Hidehito Horinouchi | Author(s): M. Maemondo, T. Hida, M. Takeda, K. Hotta, F. Hirai, Y.H. Kim, S. Matsumoto, Tetsuya Mitsudomi, Takashi Seto, S. Moizumi, K. Tokushige, B. Hatano, Makoto Nishio
- Abstract
Loading...
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)
17:00 - 17:10 | Presenter: Makoto Nishio | Author(s): K. Kiura, Takashi Seto, Kazuhiko Nakagawa, M. Maemondo, A. Inoue, T. Hida, H. Yoshioka, M. Harada, Yuichiro Ohe, N. Nogami, H. Murakami, K. Takeuchi, S. Inamura, H. Kuriki, T. Shimada, T. Tamura
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-002 - Drug-Related Pneumonitis in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Commercial PD-1 Inhibitors
09:30 - 09:30 | Presenter: Mizuki Nishino | Author(s): A.E. Adeni, H. Hatabu, C.A. Lydon, T. Hida, F..S. Hodi, M.M. Awad
- Abstract
Loading... -
+
P2.07-028 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer Patients Who Relapse after Thoracic Radiotherapy
09:30 - 09:30 | Presenter: Teppei Yamaguchi | Author(s): Y. Oya, Y. Kagawa, H. Furuta, N. Watanabe, J. Shimizu, Y. Horio, T. Uemura, S. Morikawa, K. Imaizumi, T. Hida
- Abstract
Loading...
-
+
P2.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P2.15-004 - Underrepresentation of Elderly Patients with ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)
09:30 - 09:30 | Presenter: Yuki Misumi | Author(s): Tsuneo Shimokawa, Hiroaki Okamoto, Shinji Atagi, H. Tanaka, Koichi Goto, Kazuhiko Nakagawa, T. Hida, Nobuyuki Yamamoto, Y. Hosomi, Terufumi Kato, Isamu Okamoto, Yuichiro Ohe
- Abstract
Loading...
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
MA 12.02 - Phase I/II Study of S49076, a MET/AXL/FGFR Inhibitor, Combined with Gefitinib in NSCLC Patients Progressing on EGFR TKI
11:05 - 11:10 | Presenter: Gee-Chen Chang | Author(s): G. Curigliano, Wan-Teck Lim, S. Viteri, F. Ciardiello, T. Hida, Chia-Chi Lin, H. Murakami, Makoto Nishio, Luis Paz-Ares, F. Cantero, C. Gabarroca, E. Gandossi, N. Kamsu-Kom, S. Pennaforte, M.-. Secouard-Faure, Keunchil Park
- Abstract
Loading...
-
+
MA 17 - Locally Advanced NSCLC
- 15:45 - 17:30
- 10/17/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Oral
- Track: Locally Advanced NSCLC
- Moderators:S. Jheon, Georgios Stamatis
-
+
MA 17.06 - Safety Data from Randomized Phase II Study of CDDP+S-1 vs CDDP+PEM Combined with TRT for Locally Advanced Non-Squamous NSCLC
16:20 - 16:25 | Presenter: Akira Ono | Author(s): T. Takahashi, Seiji Niho, T. Yoshida, T. Akimoto, K. Sakamaki, Takashi Seto, Makoto Nishio, N. Yamamoto, T. Hida, Hiroaki Okamoto, T. Kurata, Miyako Satouchi, Koichi Goto, T. Yamanaka, Yuichiro Ohe
- Abstract
Loading...
-
+
MA 19 - Mesothelioma: Bench to Bedside
- 11:00 - 12:30
- 10/18/2017
- Location: Room 315
- Type: Mini Oral
- Track: Mesothelioma
- Moderators:Dean A Fennell, Hedy Lee Kindler
-
+
MA 19.01 - A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)
11:00 - 11:05 | Presenter: Yasushi Goto | Author(s): Morihito Okada, T. Kijima, K. Aoe, Terufumi Kato, N. Fujimoto, Kazuhiko Nakagawa, Y. Takeda, T. Hida, K. Kanai, F. Imamura, S. Oizumi, T. Takahashi, M. Takenoyama, H. Tanaka, Yuichiro Ohe
- Abstract
Loading...
-
+
OA 10 - Liquid Biopsy for Genomic Alterations
- 11:00 - 12:30
- 10/18/2017
- Location: F201 + F202 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Adrian G. Sacher, Pasi A Jänne
-
+
OA 10.01 - Detection of EGFR mutations from plasma ctDNA in the osimertinib Phase III trial (AURA3): comparison of three plasma assays
11:00 - 11:10 | Presenter: Myung-Ju Ahn | Author(s): Ji-Youn Han, C. Tsai, A. Delmonte, T. Hsia, J. Laskin, S. Kim, Y. He, T. Hida, M. Maemondo, T. Kato, S. Jenkins, A. Markovets, K.S. Thress, T. Mok
- Abstract
Loading...
-
+
OA 17 - Immunotherapy II
- 14:30 - 16:15
- 10/18/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Immunology and Immunotherapy
- Moderators:Yuichiro Ohe, Anne Tsao
-
+
OA 17.07 - Long-Term Survival in Atezolizumab-Treated Patients with 2L+ NSCLC from Ph III Randomized OAK Study
15:35 - 15:45 | Presenter: Miyako Satouchi | Author(s): L. Fehrenbacher, Manuel Cobo Dols, Ji-Youn Han, J. Von Pawel, R. Bordoni, T. Hida, Keunchil Park, D. Moro-Sibilot, P. Conkling, C. Matheny, W. Yu, P. He, Marcin Kowanetz, M. Gandhi, M. Ballinger, A. Sandler, David R. Gandara
- Abstract
Loading...